Skip to main content

News & events

Jump to news

Featured event


More upcoming events

Kinshasa, DRC

22 Jun 2023

Science and community in the HIV response in the Democratic Republic of Congo

Séminaire scientifique post-conférence AIDS 2022 organisé en partenariat avec la Fondation Femme Plus (gratuit) IAS – the International AIDS Society – organise un séminaire scientifique de l’IAS Educational Fund en partenariat avec la Fondation Femme Plus sur le thème « Science et communautés dans la réponse au VIH en République Démocratique du Congo ». Ce séminaire se tiendra le 22 juin 2023 à Kinshasa, en République Démocratique du Congo (RDC). Ce séminaire fait suite à la 24ème Conférence Internationale sur le SIDA (AIDS 2022).  Les intervenants et les participants discuteront des sujets clés suivants: Statut de la réponse au VIH en RDC et dans la région Messages clés de la Conférence AIDS 2022 Prise en charge pédiatrique et élimination de la transmission verticale: Dernières avancées scientifiques Stratégies innovantes en matière de prévention combinée Stigmatisation et discrimination dans la réponse au VIH Ce séminaire gratuit est ouvert aux cliniciens, prestataires de services de santé et de services sociaux, chercheurs, responsables politiques, activistes, membres des populations clés et vulnérables et représentants des personnes vivants avec le VIH. Ce séminaire se déroulera en français. Inscrivez-vous maintenant   Science and community in the HIV response in the Democratic Republic of Congo The Educational Fund of IAS – the International AIDS Society – is organizing a scientific symposium in partnership with Fondation Femme Plus, titled “Science and community in the HIV response in the Democratic Republic of Congo”. The symposium is a follow up to AIDS 2022, the 24th International AIDS Conference, and will be held in Kinshasa, Democratic Republic of the Congo, on 22 June 2023. Speakers and participants will discuss the following key themes: The status of the HIV response in the DRC and the region Key messages from AIDS 2022 Latest scientific advances in paediatric care and elimination of vertical transmission Innovative combination prevention strategies An HIV response without stigma and discrimination This free symposium is open to clinicians, health and social service providers, researchers, political decision makers, activists, key and vulnerable population representatives, and people living with HIV. This symposium will be held in French.

View details View details
Person wearing green with pink head scarf

22 Jul 2023

Putting people first in the prevention, treatment and care of HPV-related cancers among people living with HIV

IAS – the International AIDS Society – and its partners are organizing a one-day pre-meeting, titled “Putting people first in the prevention, treatment and care of HPV-related cancers for people living with HIV”, in conjunction with IAS 2023, the 12th IAS Conference on HIV Science.  The event will be held at the Pullman & Mercure King George Square Hotel, Corner of Ann & Roma Street, Brisbane, 4000, Australia, on 22 July 2023. The content will be accessible online after the pre-meeting.    This pre-meeting will be of interest to HIV basic scientists, clinicians, researchers, public health practitioners, implementers, community advocates and those working towards preventing and managing HPV-related cancers.   People with HIV experience a substantially increased incidence of cancers associated with human papillomavirus (HPV), including cervical cancer, anal cancer, other anogenital cancers and oro-pharyngeal cancer. Globally, cervical cancer is the most common cancer in women living with HIV, and people living with HIV are more likely to develop cervical cancer at a younger age. Scale up of HPV vaccination, screening and treatment are required to meet the ambitious targets of the World Health Organization to eliminate cervical cancer as a public health problem by 2030. People living with HIV should be prioritized in this scale up.  Anal cancer is a common cancer in people living with HIV and is among the most common of all cancers in men having sex with men living with HIV. Like cervical cancer, future anal cancer cases will eventually be prevented by HPV vaccination of children. In addition, screening in people living with HIV, analogous to the cervical model, has been proposed. In 2022, a large, randomized trial reported for the first time that treatment of screen-detected pre-cancer reduced the incidence of anal cancer. Clinical societies will need to adjust to these new results and the reality that screening and treatment to prevent anal cancer is needed in people living with HIV.   The objective of the meeting is to bring together a diverse group of scientific, technical and community representatives to discuss current opportunities and challenges for increased prevention and screening for HPV, as well as diagnosis and treatment of intraepithelial neoplasia to prevent cervical cancer and anal cancer in people living with HIV and other populations.   Programme and Organizing Committee  Adeeba Kamarulzaman, Monash University, Malaysia Andrew Grulich, Kirby Institute, University of NSW, Australia Joel Palefsky, University of California San Francisco, United States Sinead Delany-Moretlwe, University of the Witwatersrand, South Africa Programme overview 09:00 – 10:00 Session 1 – Welcome and introduction: The scale of the challenges 10:00 – 10:30 Break 10:30 – 12:00 Session 2 – State-of-the-art guidance for vaccination, screen and treat 12:00 – 13:00 Lunch provided on site 13:00 – 14:30 Session 3 – Good-practice models for HPV cancer elimination 14:30 – 15:00 Break 15:00 – 15:45 Session 4 – Discussion: Current and future research gaps related to HPV cancer elimination 15:45 – 16:00 Break 16:00– 17:00 Session 5 – Discussion: Call to action 17:00 – 18:00 Networking reception See programme details and featured speakers here. Sign-up To encourage the broadest participation in the forum, sign-up will be free. However, the meeting will be in person only and limited to 250 attendees. Please note you may only sign up for one IAS 2023 pre-meeting. Sign up Please note that signing up for the pre-meeting does not grant you access to IAS 2023; a separate registration is required for the main event. Proudly supported by major donor and organizing partner: With support from bronze sponsor: With support from: table.table-fix { table-layout: fixed; margin-top: 32px; margin-bottom: 48px; } table.table-fix tr td { padding: 12px 16px; border-right: 2px solid #fff; } table.table-fix tr:nth-child(2n) td { background-color: #f2f5f6; }

View details View details
HIV Cure Meeting

22 Jul 2023

2023 HIV Cure & Immunotherapy Forum

The 2023 HIV Cure & Immunotherapy Forum, organized by the IAS Towards an HIV Cure initiative, will be held at the Brisbane Convention & Exhibition Centre in Brisbane, Australia, on 22 July 2023 alongside IAS 2023, the 12th IAS Conference on HIV Science. The content of the Forum will be accessible online after the meeting.   Following the success of the 2019 HIV & HBV Forum and the 2021 HIV Cure and Gene Therapy Forum, the 2023 Forum will focus on the intersection between immunotherapy and HIV cure research, building on recent advances in both fields. Its main goals are to establish a unified definition for post-intervention control, understand the biological impact of immunotherapies for cure, understand the underlying mechanisms, and learn from advances in immunotherapies in cancer therapeutics and vaccine development.  The Forum will include invited speakers, an oral abstract discussion and a panel discussion incorporating perspectives from both fields and highlighting current research directions.   Forum objectives Accelerate research on immunotherapy curative strategies. Create an environment to foster interdisciplinary collaborations and merge the HIV cure and immunotherapy disciplines. Provide an opportunity for the next generation of investigators to launch their careers through interaction and discussion with peers. Promote engagement of researchers, advocates, social and behavioural scientists, ethicists, philanthropic organizations and the private sector and seek to promote research in low- and middle-income settings. Promote increased investments in cure research. Provide a platform for information sharing, debate and networking among peers. Programme Committee  Thumbi Ndung'u, Beatriz Mothe Pujadas and Anthony Kelleher will co-chair the meeting. The Forum Programme Committee will be made up of experts from both fields and include Sharon Lewin and Steve Deeks, the inaugural Co-Chairs of the IAS Towards an HIV Cure forums.  Please see the scientific programme here. Sign-up To encourage the broadest participation in the forum, sign-up will be free. However, the meeting will be in person only and limited to 300 attendees. Please note you may only sign up for one IAS 2023 pre-meeting. Sign up Please note that signing up for the pre-meeting does not grant you access to IAS 2023; a separate registration is required for the main event.

View details View details
Munich, Germany

22 - 26 Jul 2024

The 25th International AIDS Conference

AIDS 2024, the 25th International AIDS Conference, will take place in Munich, Germany, and virtually from 22 to 26 July 2024 and is expected to bring together some 18,000 participants from around the world.

View details View details

Latest news

The White House, Washington D.C.

IAS statement: The US must heed the lessons of PEPFAR

View details
A researcher in a laboratory

IAS statement: Europe must not abandon the quest for an effective HIV vaccine

View details
LGBTQ flag

IAS statement: Abolishing anti-gay law supports the HIV response and champions human rights

View details
Trans Visibility Day Flag

IAS statement: Extend gender-affirming care to all

View details